GHD is the market leading homecare provider in Germany, delivering medical products, advice and services to more than 140,000 patients. The company operates in the German healthcare market, which is characterised by positive long-term demand driven by demographic trends.
- Longstanding expertise with +30 years in the German healthcare market.
- Integrated business model that combines the production of medical supplies and compounded pharmaceuticals with wholesale and logistics activities.
- A leading producer of custom-made infusion solutions for cytostatic drugs and parenteral nutrition.
Vision & Outlook
- Support continued accelerated growth, both organically and through acquisitions.
- Drive further growth in homecare and adjacent healthcare segments, as well as by developing new business areas.
Highlights & Updates
- Launch of new digital guidance service for home-based patients in Germany during the corona pandemic with helpful videos and hygiene tips.
EUR 590 million